HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 160 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,538,000 | -30.2% | 120,000 | -29.4% | 0.22% | -36.7% |
| Q1 2017 | $2,203,000 | +23.9% | 170,000 | -5.6% | 0.35% | +2.3% |
| Q4 2016 | $1,778,000 | -99.9% | 180,000 | -28.0% | 0.34% | -29.0% |
| Q3 2016 | $3,020,000,000 | +139844.4% | 250,000 | 0.0% | 0.48% | +25.3% |
| Q2 2016 | $2,158,000 | -47.1% | 250,000 | -42.0% | 0.38% | -52.7% |
| Q1 2016 | $4,082,000 | -42.5% | 431,000 | +5.1% | 0.81% | -24.6% |
| Q4 2015 | $7,105,000 | +207.6% | 410,000 | +138.4% | 1.07% | +191.8% |
| Q3 2015 | $2,310,000 | -40.5% | 172,000 | 0.0% | 0.37% | -21.0% |
| Q2 2015 | $3,884,000 | – | 172,000 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |